1127OA personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer. (23rd October 2018) - Ott, P A; Govindan, R; Naing, A; Friedlander, T W; Margolin, K; Lin, J J; Bhardwaj, N; Hellman, M D; Srinivasan, L; Greshock, J; Moles, M; Gaynor, R B; et al.